Aug. 6 at 6:55 PM
FTC Files Sues to Block Edwards Lifesciences’ Acquisition of JenaValve
The FTC has filed a lawsuit to stop EW from acquiring JenaValve, citing antitrust concerns. JenaValve is developing a transcatheter valve for aortic regurgitation, an area with limited current treatment options. The FTC argues the deal would eliminate a potential competitor and harm future innovation and pricing.
Edwards disagrees with the FTC and says it will continue pursuing regulatory approval, calling the acquisition a way to accelerate solutions for patients with unmet medical needs.
Shares of EW fell 0.8% on the news. The move reflects the FTC’s ongoing crackdown on healthcare M&A under Chair Lina Khan, particularly in innovation-driven markets like medtech.
$EW